H. R. 1768
Introduced in House · June 10, 2025March 3, 2025
Mr. Pallone introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Budget, the Judiciary, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
A BILL
To provide for lower costs for everyday Americans, and for other purposes.
1. Short title; 2. Table of contents; DIVISION A—RECYCLING, WATER, AND ENVIRONMENT RELATED PROVISIONS; 101. Recycling and composting accountability; 102. Recycling Infrastructure and Accessibility Program; 103. Drinking water infrastructure risk and resilience; 104. Reauthorization of Diesel Emissions Reduction Act; 105. Nationwide Consumer and Fuel Retailer Choice Act; DIVISION B—COMMERCE; TITLE I—YOUTH POISONING PREVENTION; 101. Short title; 102. Banning of products containing a high concentration of sodium nitrite; TITLE II—CONSUMER PRODUCT SAFETY STANDARD FOR CERTAIN BATTERIES; 201. Consumer product safety standard for certain batteries; TITLE III—FOREIGN ADVERSARY COMMUNICATIONS TRANSPARENCY ACT; 301. Short title; 302. List of entities holding FCC authorizations, licenses, or other grants of authority and having certain foreign ownership; TITLE IV—PROMOTING RESILIENT SUPPLY CHAINS; 401. Short title; 402. Additional responsibilities of Assistant Secretary of Commerce for Industry and Analysis; 403. Critical supply chain resilience working group; 404. Department of Commerce capability assessment; 405. No additional funds; 406. Sunset; 407. Definitions; TITLE V—DEPLOYING AMERICAN BLOCKCHAINS; 501. Short title; 502. Definitions; 503. Department of Commerce leadership on blockchain; 504. Reports to Congress; TITLE VI—FUTURE NETWORKS ACT; 601. Short title; 602. 6G task force; 603. Termination of Task Force; TITLE VII—SECURE SPACE ACT; 701. Short title; 702. Prohibition on grant of certain satellite licenses, United States market access, or earth station authorizations; TITLE VIII—TAKE IT DOWN ACT; 801. Short title; 802. Criminal prohibition on intentional disclosure of nonconsensual intimate visual depictions; 803. Notice and removal of nonconsensual intimate visual depictions; 804. Definitions; 805. Severability; TITLE IX—RURAL BROADBAND PROTECTION ACT; 901. Short title; 902. Vetting process for prospective high-cost universal service fund applicants; TITLE X—AMERICAN MUSIC TOURISM; 1001. Short title; 1002. Responsibilities of the Assistant Secretary of Commerce for Travel and Tourism; TITLE XI—INFORMING CONSUMERS ABOUT SMART DEVICES; 1101. Short title; 1102. Required disclosure of a camera or recording capability in certain internet-connected devices; 1103. Enforcement by the Federal Trade Commission; 1104. Definition of covered device; 1105. Effective date; TITLE XII—SECURING SEMICONDUCTOR SUPPLY CHAINS ACT; 1201. Short title; 1202. SelectUSA defined; 1203. Findings; 1204. Coordination with State-level economic development organizations; 1205. Report on increasing foreign direct investment in semiconductor-related manufacturing and production; 1206. No additional funds; TITLE XIII—HOTEL FEES TRANSPARENCY ACT; 1301. Short title; 1302. Prohibition on unfair and deceptive advertising of hotel rooms and other short-term rental prices; TITLE XIV—TRANSPARENCY IN CHARGES FOR KEY EVENTS TICKETING; 1401. Short title; 1402. All inclusive ticket price disclosure; 1403. Speculative ticketing ban; 1404. Disclosures; 1405. Refund requirements; 1406. Report by the Federal Trade Commission on BOTS Act of 2016 enforcement; 1407. Enforcement; 1408. Definitions; TITLE XV—ROUTERS ACT; 1501. Short title; 1502. Study of national security risks posed by certain routers and modems; TITLE XVI—NTIA REAUTHORIZATION; 1601. Short title; 1602. Definitions; 1611. Reauthorization of the National Telecommunications and Information Administration Organization Act; 1612. NTIA Consolidated Reporting Act; 1621. Office of Spectrum Management; 1631. Office of International Affairs; DIVISION C—HEALTH; TITLE I—MEDICAID; 101. Streamlined enrollment process for eligible out-of-state providers under Medicaid and CHIP; 102. Making certain adjustments to coverage of home or community-based services under Medicaid; 103. Removing certain age restrictions on Medicaid eligibility for working adults with disabilities; 104. Medicaid State plan requirement for determining residency and coverage for military families; 105. Ensuring the reliability of address information provided under the Medicaid program; 106. Codifying certain Medicaid provider screening requirements related to deceased providers; 107. Modifying certain State requirements for ensuring deceased individuals do not remain enrolled; 108. One-year delay of Medicaid and CHIP requirements for health screenings, referrals, and case management services for eligible juveniles in public institutions; State interim work plans; 109. State studies and HHS report on costs of providing maternity, labor, and delivery services; 110. Modifying certain disproportionate share hospital allotments; 111. Modifying certain limitations on disproportionate share hospital payment adjustments under the Medicaid program; 112. Ensuring accurate payments to pharmacies under Medicaid; 113. Preventing the use of abusive spread pricing in Medicaid; TITLE II—MEDICARE; 201. Extension of increased inpatient hospital payment adjustment for certain low-volume hospitals; 202. Extension of the Medicare-dependent hospital (MDH) program; 203. Extension of add-on payments for ambulance services; 204. Extending incentive payments for participation in eligible alternative payment models; 205. Temporary payment increase under the Medicare physician fee schedule to account for exceptional circumstances; 206. Extension of funding for quality measure endorsement, input, and selection; 207. Extension of funding outreach and assistance for low-income programs; 208. Extension of the work geographic index floor; 209. Extension of certain telehealth flexibilities; 210. Requiring modifier for use of telehealth to conduct face-to-face encounter prior to recertification of eligibility for hospice care; 211. Extending acute hospital care at home waiver flexibilities; 212. Enhancing certain program integrity requirements for DME under Medicare; 213. Guidance on furnishing services via telehealth to individuals with limited English proficiency; 214. In-home cardiopulmonary rehabilitation flexibilities; 215. Inclusion of virtual diabetes prevention program suppliers in MDPP Expanded Model; 216. Medication-induced movement disorder outreach and education; 217. Report on wearable medical devices; 218. Extension of temporary inclusion of authorized oral antiviral drugs as covered part D drugs; 219. Extension of adjustment to calculation of hospice cap amount; 220. Multiyear contracting authority for MedPAC and MACPAC; 221. Contracting parity for MedPAC and MACPAC; 222. Adjustments to Medicare part D cost-sharing reductions for low-income individuals; 223. Requiring Enhanced and Accurate Lists of (REAL) Health Providers Act; 224. Medicare coverage of multi-cancer early detection screening tests; 225. Medicare coverage of external infusion pumps and non-self-administrable home infusion drugs; 226. Assuring pharmacy access and choice for Medicare beneficiaries; 227. Modernizing and Ensuring PBM Accountability; 228. Requiring a separate identification number and an attestation for each off-campus outpatient department of a provider; 229. Medicare sequestration; TITLE III—OTHER MATTERS; 301. Sexual risk avoidance education extension; 302. Personal responsibility education extension; 303. Extension of funding for family-to-family health information centers; TITLE IV—PUBLIC HEALTH EXTENDERS; 401. Extension for community health centers, National Health Service Corps, and teaching health centers that operate GME programs; 402. Extension of special diabetes programs; 411. 9/11 responder and survivor health funding corrections; TITLE V—SUPPORT ACT REAUTHORIZATION; 501. Short title; 511. Prenatal and postnatal health; 512. Monitoring and education regarding infections associated with illicit drug use and other risk factors; 513. Preventing overdoses of controlled substances; 514. Support for individuals and families impacted by fetal alcohol spectrum disorder; 515. Promoting state choice in PDMP systems; 516. First responder training program; 517. Donald J. Cohen National Child Traumatic Stress Initiative; 518. Protecting suicide prevention lifeline from cybersecurity incidents; 519. Bruce’s law; 520. Guidance on at-home drug disposal systems; 521. Assessment of opioid drugs and actions; 522. Grant program for State and Tribal response to opioid use disorders; 531. Residential treatment program for pregnant and postpartum women; 532. Improving access to addiction medicine providers; 533. Mental and behavioral health education and training grants; 534. Loan repayment program for substance use disorder treatment workforce; 535. Development and dissemination of model training programs for substance use disorder patient records; 536. Task force on best practices for trauma-informed identification, referral, and support; 537. Grants to enhance access to substance use disorder treatment; 538. State guidance related to individuals with serious mental illness and children with serious emotional disturbance; 539. Reviewing the scheduling of approved products containing a combination of buprenorphine and naloxone; 541. Building communities of recovery; 542. Peer support technical assistance center; 543. Comprehensive opioid recovery centers; 544. Youth prevention and recovery; 545. CAREER Act; 546. Addressing economic and workforce impacts of the opioid crisis; 551. Delivery of a controlled substance by a pharmacy to a prescribing practitioner; 552. Technical correction on controlled substances dispensing; 553. Required training for prescribers of controlled substances; 554. Extension of temporary order for fentanyl-related substances; TITLE VI—PANDEMIC AND ALL-HAZARDS PREPAREDNESS AND RESPONSE; 601. Short title; 611. Temporary reassignment of State and local personnel during a public health emergency; 612. Public Health Emergency Preparedness program; 613. Hospital Preparedness Program; 614. Facilities and capacities of the Centers for Disease Control and Prevention to combat public health security threats; 615. Pilot program to support State medical stockpiles; 616. Enhancing domestic wastewater surveillance for pathogen detection; 617. Reauthorization of Mosquito Abatement for Safety and Health program; 621. All-Hazards Emergency Preparedness and Response; 622. National Health Security Strategy; 623. Improving development and distribution of diagnostic tests; 624. Combating antimicrobial resistance; 625. Strategic National Stockpile and material threats; 626. Medical countermeasures for viral threats with pandemic potential; 627. Public Health Emergency Medical Countermeasures Enterprise; 628. Fellowship and training programs; 629. Regional biocontainment research laboratories; 629A. Limitation related to countries of concern conducting certain research; 631. Improving access to certain programs; 632. Supporting at-risk individuals during emergency responses; 633. National advisory committees; 634. National Academies study on prizes; 641. Medical countermeasure priority review voucher; 642. Epidemic Intelligence Service; 643. Monitoring and distribution of certain medical countermeasures; 644. Regional health care emergency preparedness and response systems; 645. Emergency system for advance registration of volunteer health professionals; 646. Ensuring collaboration and coordination in medical countermeasure development; 647. Military and civilian partnership for trauma readiness; 648. National Disaster Medical System; 649. Volunteer Medical Reserve Corps; 650. Epidemiology-laboratory capacity; TITLE VII—PUBLIC HEALTH PROGRAMS; 701. Action for dental health; 702. PREEMIE; 703. Preventing maternal deaths; 704. Sickle cell disease prevention and treatment; 705. Traumatic brain injuries; 706. Lifespan respite care; 707. Dr. Lorna Breen health care provider protection; 708. Conforming amendment to Internal Revenue Code of 1986; 709. SCREENS for Cancer; 710. DeOndra Dixon INCLUDE Project; 711. IMPROVE Initiative; 712. Organ Procurement and Transplantation Network; 713. Honor Our Living Donors; 714. Program for pediatric studies of drugs; TITLE VIII—FOOD AND DRUG ADMINISTRATION; 801. Research into pediatric uses of drugs; additional authorities of Food and Drug Administration regarding molecularly targeted cancer drugs; 802. Ensuring completion of pediatric study requirements; 803. FDA report on PREA enforcement; 804. Extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases; 805. Limitations on exclusive approval or licensure of orphan drugs; 811. Establishment of Abraham Accords Office within Food and Drug Administration; TITLE IX—LOWERING PRESCRIPTION DRUG COSTS; 901. Oversight of pharmacy benefit management services; 902. Full rebate pass through to plan; exception for innocent plan fiduciaries; 903. Increasing transparency in generic drug applications; 904. Title 35 amendments; TITLE X—MISCELLANEOUS; 1001. Two-year extension of safe harbor for absence of deductible for telehealth